2-alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia

Details for Australian Patent Application No. 2004273659 (hide)

Owner Pfizer Products Inc.

Inventors Lee, Andrew George

Agent Shelston IP

Pub. Number AU-A-2004273659

PCT Pub. Number WO2005/027914

Priority 60/504,509 19.09.03 US

Filing date 6 September 2004

Wipo publication date 31 March 2005

International Classifications

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/027914 Priority application(s): WO2005/027914

31 January 2008 Assignment before Grant

  Pifizer Products Inc. The application has been assigned to Wisconsin Alumni Research Foundation

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273660-Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone

2004273658-Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist